Subscribe To
Shionogi & co., ltd. (sgiof) q1 2023 earnings call transcript
Shionogi & Co., Ltd. (OTCPK:SGIOF) Q1 2023 Earnings Conference Call July 31, 2023 5:15 AM ET Company Participants Yoshimasa Kyokawa - VP, Corporate Co...
July 31, 2023, 8:37 pm
Biomarin pharmaceutical, inc. (bmrn) q2 2023 earnings call transcript
Biomarin pharmaceutical, Inc. (NASDAQ:BMRN ) Q2 2023 Earnings Conference Call July 31, 2023 4:30 PM ET ...
July 31, 2023, 8:14 pm
Monster beverage completes acquisition of bang energy
CORONA, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ: MNST) today announced that its subsidiary, Blast Asset Acquis...
July 31, 2023, 8:10 pm
Bicycle therapeutics: decent upside opportunity, mid-stage data readouts due
Bicycle Therapeutics is an intriguing play in the drug development space. Using its fully synthetic short peptides, the company has developed two mid-...
July 31, 2023, 7:07 pm
Biomarin pharmaceutical (bmrn) tops q2 earnings and revenue estimates
BioMarin pharmaceutical (BMRN) came out with quarterly earnings of $0.54 per share, beating the Zacks C...
July 31, 2023, 6:38 pm
Macrogenics announces date of second quarter 2023 financial results conference call
ROCKVILLE, MD, July 31, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical ...
July 31, 2023, 5:35 pm
Bolt biotherapeutics to present at btig virtual biotechnology conference 2023
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage bio...
July 31, 2023, 5:27 pm
Mineralys therapeutics to announce second quarter 2023 financial results and host conference call on monday, august 7, 2023
RADNOR, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage bio...
July 31, 2023, 4:05 pm
Gracell biotechnologies to report second quarter 2023 financials on monday, august 14, 2023
SAN DIEGO and SUZHOU, China and SHANGHAI, China, July 31, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a glob...
July 31, 2023, 4:02 pm
Spero therapeutics shares rise on fda approval of pivotal complicated uti trial
Spero Therapeutics shares soared after the clinical-stage biopharmaceutical company announced that it h...
July 31, 2023, 3:42 pm
Ani pharmaceuticals (anip) to post q2 earnings: what's in store?
ANI pharmaceuticals' (ANIP) second-quarter 2023 performance is likely to have been driven by rising gen...
July 31, 2023, 12:38 pm
Spero therapeutics announces special protocol assessment agreement with fda for phase 3 pivot-po trial of tebipenem hbr
Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30 million development milestone payment from...
July 31, 2023, 12:05 pm
Crinetics hosting key opinion leader webinar to discuss the current treatment landscape and unmet need in acromegaly
Webinar Being Held on August 8, 2023 at 12:00 p.m. Eastern Time SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) — Crinetics ...
July 31, 2023, 12:01 pm
Clearside biomedical highlights excellent safety profile of cls-ax and potential for extended duration of effect in data presentation at the american society of retina specialists 41st annual scientif
– Suprachoroidal Injection of CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months – ALPHARETTA, Ga., July 31, 2...
July 31, 2023, 11:05 am
Clearside biomedical highlights excellent safety profile of cls-ax and potential for extended duration of effect in data presentation at the american society of retina specialists 41st annual scientif
– Suprachoroidal Injection of CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months – ALPHARETTA, Ga., July 31, 2...
July 31, 2023, 11:05 am
Apellis pharmaceuticals, inc. (apls) reports q2 loss, tops revenue estimates
Apellis pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $1.02 per share versus the Zacks...
July 31, 2023, 9:38 am
Mckesson (mck) to report q1 earnings: is a beat in store?
McKesson's (MCK) fiscal first-quarter 2024 results are likely to reflect the solid display by the U.S. pharmac...
July 31, 2023, 9:38 am
Why is navidea biopharmaceutical (navb) stock down 13% today?
Navidea Biopharmaceutical (NYSEMKT: NAVB ) stock is falling on Monday after the bio...
July 31, 2023, 9:08 am
Ani pharmaceuticals to discuss second quarter 2023 financial results on august 9, 2023, at 8:30 a.m. et
BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI pharmaceuticals, Inc. (“ANI” or the “Compa...
July 31, 2023, 7:17 am
Protalix biotherapeutics to announce second quarter 2023 financial and business results on august 7, 2023
Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , July 31, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Amer...
July 31, 2023, 6:50 am